1. Home
  2. INVZ vs PROK Comparison

INVZ vs PROK Comparison

Compare INVZ & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVZ
  • PROK
  • Stock Information
  • Founded
  • INVZ 2016
  • PROK 2015
  • Country
  • INVZ Israel
  • PROK United States
  • Employees
  • INVZ N/A
  • PROK N/A
  • Industry
  • INVZ Auto Parts:O.E.M.
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INVZ Consumer Discretionary
  • PROK Health Care
  • Exchange
  • INVZ Nasdaq
  • PROK Nasdaq
  • Market Cap
  • INVZ 154.6M
  • PROK 126.8M
  • IPO Year
  • INVZ N/A
  • PROK N/A
  • Fundamental
  • Price
  • INVZ $0.62
  • PROK $0.84
  • Analyst Decision
  • INVZ Strong Buy
  • PROK Buy
  • Analyst Count
  • INVZ 5
  • PROK 4
  • Target Price
  • INVZ $3.24
  • PROK $5.00
  • AVG Volume (30 Days)
  • INVZ 3.3M
  • PROK 434.6K
  • Earning Date
  • INVZ 05-07-2025
  • PROK 05-09-2025
  • Dividend Yield
  • INVZ N/A
  • PROK N/A
  • EPS Growth
  • INVZ N/A
  • PROK N/A
  • EPS
  • INVZ N/A
  • PROK N/A
  • Revenue
  • INVZ $24,268,000.00
  • PROK $76,000.00
  • Revenue This Year
  • INVZ $135.37
  • PROK N/A
  • Revenue Next Year
  • INVZ $132.60
  • PROK N/A
  • P/E Ratio
  • INVZ N/A
  • PROK N/A
  • Revenue Growth
  • INVZ 16.25
  • PROK N/A
  • 52 Week Low
  • INVZ $0.45
  • PROK $0.80
  • 52 Week High
  • INVZ $3.14
  • PROK $4.44
  • Technical
  • Relative Strength Index (RSI)
  • INVZ 32.56
  • PROK 29.40
  • Support Level
  • INVZ $0.59
  • PROK $0.87
  • Resistance Level
  • INVZ $0.76
  • PROK $1.00
  • Average True Range (ATR)
  • INVZ 0.05
  • PROK 0.10
  • MACD
  • INVZ 0.01
  • PROK 0.01
  • Stochastic Oscillator
  • INVZ 17.51
  • PROK 14.70

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks, and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.

Share on Social Networks: